AVAH Q2 Earnings Call Highlights Higher Growth Targets

Aveanna raises its 2026 outlook and long-term growth targets as reimbursement gains and preferred payers support expansion.

Zacks Investment Research • Aug 14, 2026

Aveanna Healthcare Q2 Earnings Call Highlights

Aveanna Healthcare NASDAQ: AVAH reported higher second-quarter revenue and adjusted EBITDA, supported by growth across its three operating divisions, improved reimbursement rates, increased volumes and operational efficiencies. The company also raised its full-year outlook and updated its long-term organic growth targets for its Private Duty Services and Home Health and Hospice businesses.

MarketBeat • Aug 13, 2026

Aveanna Healthcare: Q2 Earnings Report Boosts The Stock And Reinforces My Buy Rating

Aveanna Healthcare Holdings delivered strong Q2 2026 results, beating earnings and revenue estimates and significantly raising full-year EBITDA and revenue guidance. AVAH's valuation remains attractive versus peers, with the lowest forward P/E multiples and leading EBITDA margin, despite a 60% stock price gain since March. Private Duty Services drive 83% of revenues, but gross margins declined across all segments; rapid revenue growth offset margin pressure, yet this trend warrants monitoring.

Seeking Alpha • Aug 13, 2026

Aveanna Healthcare Holdings Inc. (AVAH) Q2 2026 Earnings Call Transcript

Aveanna Healthcare Holdings Inc. (AVAH) Q2 2026 Earnings Call Transcript

Seeking Alpha • Aug 13, 2026

Aveanna Healthcare Holdings Announces Second Quarter Financial Results and Revised 2026 Guidance

Second Quarter Revenue was $670.5 million, a 13.7% increase over the prior year period Second Quarter Net income was $40.3 million compared to $27.0 million for the prior year period Adjusted EBITDA for Q2 2026 was $95.4 million, an 8.0% increase over the prior year period Increased Full Year 2026 Revenue guidance to greater than $2.68 billion, updated from between $2.63 and $2.65 billion Increased Full Year 2026 Adjusted EBITDA guidance to greater than $365 million, updated from between $338 and $342 million ATLANTA, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced financial results for the three and six-month periods ended July 4, 2026. Jeff Shaner, Chief Executive Officer, commented, “Our second quarter results demonstrate the momentum across Aveanna and our ability to consistently deliver sustained year-over-year growth.

GlobeNewsWire • Aug 13, 2026

Aveanna Healthcare (AVAH) Beats Q2 Earnings and Revenue Estimates

Aveanna Healthcare (AVAH) came out with quarterly earnings of $0.22 per share, beating the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.18 per share a year ago.

Zacks Investment Research • Aug 13, 2026

Aveanna (AVAH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Aveanna (AVAH) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks Investment Research • Aug 13, 2026

Gear Up for Aveanna (AVAH) Q2 Earnings: Wall Street Estimates for Key Metrics

Besides Wall Street's top-and-bottom-line estimates for Aveanna (AVAH), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2026.

Zacks Investment Research • Aug 10, 2026

Is the Options Market Predicting a Spike in Aveanna Healthcare Stock?

Investors need to pay close attention to AVAH stock based on the movements in the options market lately.

Zacks Investment Research • Aug 10, 2026

Will Lower PDS Margin Affect Aveanna Healthcare's Q2 Earnings?

AVAH's Q2 revenues are expected to rise 9.8%, but lower PDS margins and higher costs may weigh on earnings.

Zacks Investment Research • Aug 10, 2026